Waheed Nadia bought OCUL
February 11, 2025 · Form 4 insider transaction
Waheed Nadia bought 237,000 shares of Ocular Therapeutix, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
237,000
Price
$0.00
Total value
N/A
InsiderWaheed Nadia
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2025
Filing dateFebruary 13, 2025
Shares owned after237,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.